NEW YORK (GenomeWeb) – A collaboration between Johnson & Johnson subsidiary Janssen Diagnostics and Biocartis has so far yielded three prototype infectious disease assays for Biocartis' Idylla molecular diagnostics platform.
Scientists from Janssen presented tests for hepatitis C viral load, influenza A/B and RSV, and influenza surveillance at last month's Clinical Virology Symposium in Daytona Beach, Florida. Preliminary assessments of the assays described high specificities and lauded the ease of the cartridge-based Idylla system.